Introducing a new monthly feature focused on various tranches and rounds of funding for healthcare ventures, startups and funds. Links indicate target companies and lead investors.
| Target | Investors | Amount | Date |
|---|---|---|---|
| Catalia Health | Khosla Ventures | $2.5 million seed extension round | May 1, 2017 |
| ReThink Medical | Emergent Medical Partners, Norwich Ventures and Launch Capital | $3 million Series A | May 1, 2017 |
| Teewinot Life Sciences Corporation | Tuatara Capital | $12.3 million Series B | May 1, 2017 |
| TetraGenetics | JDRF T1 Fund | Not disclosed | May 2, 2017 |
| Lantern Pharma | Bios Partners, GPG Ventures and others | $3.7 million Series A | May 2, 2017 |
| ExoCoBio Inc. | SBI InvestmentSBI Investment, Atinum Investment, ID Ventures and Dt&Investment | $11 million Series A | May 3, 2017 |
| EverlyWell | NextGen Venture Partners, Jack Novak, SoGal Ventures, Full Tilt Capital and others | $2.5 million | May 3, 2017 |
| Vivet Therapeutics | Novartis Venture Fund, Columbus Venture Partners, Roche Venture Fund, HealthCap, Kurma Partners and Ysios Capital | USD$40,981,874 (€37.5 million) Series A | May 4, 2017 |
| PreparedHealtPreparedHealthh | Chicago Ventures, Pritzker Group Venture Capital, Beverly Capital and Meridian Street Capital | $4 million seed funding | May 4, 2017 |
| Artemis Health | Maverick Ventures | $8.3 million | May 8, 2017 |
| Advanced Medical Pricing Solutions, Inc. | Cimarron Healthcare Capital, RAF Industries and Leavitt Equity Partners | Recap | May 10, 2017 |
| Genoa Pharmaceuticals | F-Prime Capital Partners and Edmond de Rothschild Investment Partners. | $62 million Series A | May 15, 2017 |
| Highland Capital Management Korea Ltd. healthcare fund | South Korea's National Pension Service, anchor investor | $147 million | May 14, 2017 |
| Upfront Healthcare Services | Nashville Capital Network, with Echo Health Ventures, Hyde Park Venture Partners and Martin Ventures | $5.6 million | May 17, 2017 |
| Vericred | FCA Venture Partners | $5.5 million Series A | May 18, 2017 |
| Lemonaid Health | Novartis Venture Fund and Himka Ventures, with Correlation Ventures, Adaptive Healthcare Fund, Vega Ventures and 415 Ventures | $11 million Series A | May 22, 2017 |
| Anaconda Biomed | Ysios Capital, Omega Funds, Banco Sadabell and Innogest Capital | €15 million Series A | May 22, 2017 |
| Hound Labs, Inc. | Benchmark Capital | $8.1 million | May 23, 2017 |
| CANbridge Life Sciences | Lapam Capital, with Qiming Venture Partners, Yuanming Capital, Yanyuan Capital, Biossom Investment Management and Wuxi App Tec. | $25 million | May 23, 2017 |
| TP Therapeutics | OrbiMed | $45 million Series C | May 23, 2017 |
| Harpoon Therapeutics | Arix Bioscience and New Leaf Venture Partners, with Taiho Ventures and MPM Capital | $45 million Series B | May 25, 2017 |
| Viz | Alphabet's Innovation Endeavors, DHVC, AME Cloud Ventures and Susa Ventures | $4.7 million first round | May 25, 2017 |
| Medrio | Questa Capital Management | $30 million | May 25, 2017 |
